| scholarly article | Q13442814 |
| P50 | author | Kristine L Willett | Q108366135 |
| Kip M. Connor | Q40460422 | ||
| P2093 | author name string | J Chen | |
| A Stahl | |||
| L E H Smith | |||
| N M Krah | |||
| P Sapieha | |||
| R J Dennison | |||
| K I Guerin | |||
| P2860 | cites work | Oxygen-induced retinopathy in mice: amplification by neonatal IGF-I deficit and attenuation by IGF-I administration | Q46192415 |
| Breakthrough of the year. | Q51926288 | ||
| Effects of intraocular or systemic administration of neutralizing antibody against vascular endothelial growth factor on the murine experimental model of retinopathy | Q58207697 | ||
| Oxygen-induced retinopathy in the mouse | Q71608431 | ||
| Regulation of vascular endothelial growth factor-dependent retinal neovascularization by insulin-like growth factor-1 receptor | Q73226153 | ||
| Diltiazem reduces retinal neovascularization in a mouse model of oxygen induced retinopathy | Q74601747 | ||
| T2-TrpRS inhibits preretinal neovascularization and enhances physiological vascular regrowth in OIR as assessed by a new method of quantification | Q28594370 | ||
| Ranibizumab for neovascular age-related macular degeneration | Q29617549 | ||
| Genetic and pharmacological inhibition of JNK ameliorates hypoxia-induced retinopathy through interference with VEGF expression | Q33443692 | ||
| Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins | Q33775844 | ||
| Vascular endothelial growth factor (VEGF) as a target of bevacizumab in cancer: from the biology to the clinic | Q34569109 | ||
| Vascular endothelial growth factor/vascular permeability factor expression in a mouse model of retinal neovascularization | Q34749337 | ||
| Blockade of vascular endothelial cell growth factor receptor signaling is sufficient to completely prevent retinal neovascularization | Q35745444 | ||
| Increased dietary intake of omega-3-polyunsaturated fatty acids reduces pathological retinal angiogenesis | Q35817458 | ||
| Erythropoietin deficiency decreases vascular stability in mice. | Q36404124 | ||
| Inhibition of retinal neovascularisation by gene transfer of soluble VEGF receptor sFlt-1. | Q44763476 | ||
| An increase in superoxide dismutase ameliorates oxygen-induced retinopathy in transgenic mice | Q44962558 | ||
| Marked inhibition of retinal neovascularization in rats following soluble-flt-1 gene transfer | Q45047728 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | neovascularization | Q1281049 |
| P304 | page(s) | 297-301 | |
| P577 | publication date | 2009-01-01 | |
| P1433 | published in | Angiogenesis | Q15753544 |
| P1476 | title | Computer-aided quantification of retinal neovascularization | |
| P478 | volume | 12 |
| Q84120622 | 17-Alpha-estradiol ameliorating oxygen-induced retinopathy in a murine model |
| Q37011389 | 5-Lipoxygenase metabolite 4-HDHA is a mediator of the antiangiogenic effect of ω-3 polyunsaturated fatty acids |
| Q50421078 | A machine learning approach for automated assessment of retinal vasculature in the oxygen induced retinopathy model. |
| Q42377492 | ADAM10-Dependent Signaling Through Notch1 and Notch4 Controls Development of Organ-Specific Vascular Beds. |
| Q48183508 | Abscisic acid: an antiangiogenic phytohormone that modulates the phenotypical plasticity of endothelial cells and macrophages |
| Q39455385 | Animal models of ocular angiogenesis: from development to pathologies |
| Q42548814 | Assessment of vascular regeneration in the CNS using the mouse retina |
| Q36102528 | BMP9/ALK1 inhibits neovascularization in mouse models of age-related macular degeneration |
| Q91622325 | Bcl-2 Expression in Pericytes and Astrocytes Impacts Vascular Development and Homeostasis |
| Q36383866 | Bim expression in endothelial cells and pericytes is essential for regression of the fetal ocular vasculature |
| Q41185985 | Cell-specific impact of nitric oxide-dependent guanylyl cyclase on arteriogenesis and angiogenesis in mice |
| Q36082268 | Cnidium officinale extract and butylidenephthalide inhibits retinal neovascularization in vitro and in vivo |
| Q56374651 | Consensus guidelines for the use and interpretation of angiogenesis assays |
| Q35239541 | Dietary ω-3 polyunsaturated fatty acids decrease retinal neovascularization by adipose-endoplasmic reticulum stress reduction to increase adiponectin |
| Q41989268 | Effect of Guibi-Tang, a Traditional Herbal Formula, on Retinal Neovascularization in a Mouse Model of Proliferative Retinopathy |
| Q55400170 | Effect of human very low-density lipoproteins on cardiotrophin-like cytokine factor 1 (CLCF1) activity. |
| Q35441276 | Endothelial TWIST1 promotes pathological ocular angiogenesis. |
| Q35776933 | Endothelial microRNA-150 is an intrinsic suppressor of pathologic ocular neovascularization |
| Q36211402 | Endothelium Expression of Bcl-2 Is Essential for Normal and Pathological Ocular Vascularization |
| Q37605212 | Fenofibrate Inhibits Cytochrome P450 Epoxygenase 2C Activity to Suppress Pathological Ocular Angiogenesis |
| Q47573161 | Fully automated, deep learning segmentation of oxygen-induced retinopathy images |
| Q36094613 | Fzd4 Haploinsufficiency Delays Retinal Revascularization in the Mouse Model of Oxygen Induced Retinopathy |
| Q57116127 | Gαi1 and Gαi3mediate VEGF-induced VEGFR2 endocytosis, signaling and angiogenesis |
| Q36997322 | Hydrogen Sulfide Contributes to Retinal Neovascularization in Ischemia-Induced Retinopathy |
| Q34544365 | Hyperoxia causes regression of vitreous neovascularization by downregulating VEGF/VEGFR2 pathway |
| Q35221114 | Hyperoxia therapy of pre-proliferative ischemic retinopathy in a mouse model |
| Q40218186 | Inflammatory signals from photoreceptor modulate pathological retinal angiogenesis via c-Fos. |
| Q58079569 | Intravitreal Delivery of VEGF-A-loaded PLGA Microparticles Reduces Retinal Vaso-Obliteration in an in Vivo Mouse Model of Retinopathy of Prematurity |
| Q36581303 | Intravitreal injection of TIMP3 or the EGFR inhibitor erlotinib offers protection from oxygen-induced retinopathy in mice. |
| Q90685529 | Intriguing Roles for Endothelial ADAM10/Notch Signaling in the Development of Organ-Specific Vascular Beds |
| Q40035151 | Involvement of CD24 in angiogenesis in a mouse model of oxygen-induced retinopathy |
| Q35037440 | Ischemic neurons prevent vascular regeneration of neural tissue by secreting semaphorin 3A |
| Q35886090 | Lack of netrin-4 modulates pathologic neovascularization in the eye |
| Q37011339 | Lipid metabolites in the pathogenesis and treatment of neovascular eye disease |
| Q91632216 | Long-term evaluation of retinal morphology and function in a mouse model of oxygen-induced retinopathy |
| Q64066778 | MicroRNA-145 Regulates Pathological Retinal Angiogenesis by Suppression of TMOD3 |
| Q35193348 | Modulation of radiation injury response in retinal endothelial cells by quinic acid derivative KZ-41 involves p38 MAPK. |
| Q55035369 | Neurofibromin Deficiency Induces Endothelial Cell Proliferation and Retinal Neovascularization. |
| Q39115933 | Neuronal sirtuin1 mediates retinal vascular regeneration in oxygen-induced ischemic retinopathy. |
| Q43171711 | Neuropilin-1 mediates myeloid cell chemoattraction and influences retinal neuroimmune crosstalk. |
| Q90562874 | Nogo-A inhibits vascular regeneration in ischemic retinopathy |
| Q34168399 | Notch3 Is Critical for Proper Angiogenesis and Mural Cell Investment |
| Q50602764 | Nox4 supports proper capillary growth in exercise and retina neo-vascularization. |
| Q42425245 | Nuclear localization of platelet-activating factor receptor controls retinal neovascularization |
| Q38713219 | Pathogenic Role of microRNA-21 in Diabetic Retinopathy Through Downregulation of PPARα. |
| Q41630160 | Pharmacologic Activation of Wnt Signaling by Lithium Normalizes Retinal Vasculature in a Murine Model of Familial Exudative Vitreoretinopathy |
| Q31018385 | Pooling and Analysis of Published in Vitro Data: A Proof of Concept Study for the Grouping of Nanoparticles |
| Q34358139 | Postnatal weight gain modifies severity and functional outcome of oxygen-induced proliferative retinopathy. |
| Q36035023 | Propranolol inhibition of β-adrenergic receptor does not suppress pathologic neovascularization in oxygen-induced retinopathy |
| Q38430298 | RORα modulates semaphorin 3E transcription and neurovascular interaction in pathological retinal angiogenesis |
| Q64937118 | Retinal Vasculature in Development and Diseases. |
| Q34137571 | Retinal expression of Wnt-pathway mediated genes in low-density lipoprotein receptor-related protein 5 (Lrp5) knockout mice. |
| Q36772416 | Retinal lipid and glucose metabolism dictates angiogenesis through the lipid sensor Ffar1. |
| Q34090125 | Retinopathy of prematurity: understanding ischemic retinal vasculopathies at an extreme of life |
| Q37155762 | Revisiting the mouse model of oxygen-induced retinopathy. |
| Q36919959 | Role of the retinal vascular endothelial cell in ocular disease |
| Q36305360 | SOCS3 is an endogenous inhibitor of pathologic angiogenesis. |
| Q33603655 | Sema3f Protects Against Subretinal Neovascularization In Vivo |
| Q51353487 | Senescence-associated secretory phenotype contributes to pathological angiogenesis in retinopathy. |
| Q34287296 | Short communication: PPAR gamma mediates a direct antiangiogenic effect of omega 3-PUFAs in proliferative retinopathy |
| Q36103389 | Sildenafil attenuates vaso-obliteration and neovascularization in a mouse model of retinopathy of prematurity. |
| Q35085010 | Sirtuin1 over-expression does not impact retinal vascular and neuronal degeneration in a mouse model of oxygen-induced retinopathy. |
| Q85302060 | Subcellular localization of coagulation factor II receptor-like 1 in neurons governs angiogenesis |
| Q37577284 | TWEAK/Fn14 pathway is a novel mediator of retinal neovascularization |
| Q91631733 | Targeted deletion of Cyp1b1 in pericytes results in attenuation of retinal neovascularization and trabecular meshwork dysgenesis |
| Q41625520 | Tetrahydrobiopterin (BH4) deficiency is associated with augmented inflammation and microvascular degeneration in the retina |
| Q36753726 | The Eyes Absent Proteins in Developmental and Pathological Angiogenesis |
| Q40217500 | The effect of baicalin in a mouse model of retinopathy of prematurity |
| Q30495106 | The mouse retina as an angiogenesis model |
| Q50144485 | The mouse retina in 3D: quantification of vascular growth and remodeling. |
| Q26852080 | The unfolded protein response in retinal vascular diseases: implications and therapeutic potential beyond protein folding |
| Q28594681 | The vitreous glycoprotein opticin inhibits preretinal neovascularization |
| Q57029279 | Thrombocytopenia is associated with severe retinopathy of prematurity |
| Q41550097 | VEGF amplifies transcription through ETS1 acetylation to enable angiogenesis |
| Q47224207 | Vitamin D receptor expression is essential during retinal vascular development and attenuation of neovascularization by 1, 25(OH)2D3. |
| Q42546329 | Wnt signaling mediates pathological vascular growth in proliferative retinopathy |
| Q48096036 | p75NTR and Its Ligand ProNGF Activate Paracrine Mechanisms Etiological to the Vascular, Inflammatory, and Neurodegenerative Pathologies of Diabetic Retinopathy. |
Search more.